Amgen Czech Republic made a net profit of CZK 35.8 mil in 2015, down 11.4% when compared to the last year. Total sales reached CZK 604 mil, which is down 5.06% when compared to the previous year.
Historically, the company’s net profit reached an all time high of CZK 46.2 mil in 2011 and an all time low of CZK 9.88 mil in 2007.
In terms of sales, Amgen Czech Republic reached an all time high of CZK 637 mil in 2014 and an all time low of CZK 135 mil in 2006.
Amgen Czech Republic's net profit has grown 4.05% a year on average in the last five years while sales have increased by 11.0% a year since 2010.
The firm generated its shareholders an average return on invested capital of 38.1% in the last five years.
As far as Amgen Czech Republic's peers are concerned, Roche Czech Republic posted a net profit and sales of CZK 51.0 mil and CZK 5,445 mil in 2015 and Bayer Czech Republic generated a net profit of CZK 123 mil (with sales of CZK 4,277 mil).